Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.
about
Control of CD56 expression and tumor cell cytotoxicity in human Vgamma2Vdelta2 T cells.Effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and rosiglitazone on human gammadelta2 T cells.The feature of distribution and clonality of TCR γ/δ subfamilies T cells in patients with B-cell non-Hodgkin lymphoma.Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia modelImpact of age, gender, and race on circulating γδ T cells.Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells.Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.Plasticity of γδ T Cells: Impact on the Anti-Tumor ResponseRapamycin increases the yield and effector function of human γδ T cells stimulated in vitro.Immunotherapy for head and neck cancer: advances and deficiencies.Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy.Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.Impact of persistent HIV replication on CD4 negative Vγ2Vδ2 T cells.Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy.Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production.Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications.TNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells.Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cellsHeterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals.Human γδT-cell subsets and their involvement in tumor immunity.Human Vγ9Vδ2-T cells efficiently kill influenza virus-infected lung alveolar epithelial cells.Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells.Understanding the complexity of γδ T-cell subsets in mouse and human.The multifunctionality of human Vγ9Vδ2 γδ T cells: clonal plasticity or distinct subsets?Role of gamma-delta T-cells in cancer: another opening door to immunotherapy.Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.Potential of human γδ T cells for immunotherapy of osteosarcoma.mTOR inhibitors in renal cell carcinoma.Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture.Activation of cytokine-producing and antitumor activities of natural killer cells and macrophages by engagement of Toll-like and NOD-like receptors.Vγ4+γδT Cells Aggravate Severe H1N1 Influenza Virus Infection-Induced Acute Pulmonary Immunopathological Injury via Secreting Interleukin-17A.CD56 in the Immune System: More Than a Marker for Cytotoxicity?Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2(+) γδ T cell cytotoxicity in a perforin-dependent manner.Interleukin-18 activates Vγ9Vδ2+ T cells from HIV-positive individuals: recovering the response to phosphoantigen.Immune-Stimulatory Effects of Rapamycin Are Mediated by Stimulation of Antitumor γδ T Cells.Granzyme B mediated function of Parvovirus B19-specific CD4(+) T cells.Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism.
P2860
Q33505805-8D099DEC-32E5-4AAF-8BAD-2BDECBBA4F2DQ33514867-5EB968DB-2FCD-4F23-8BB5-6E855B1D2957Q33747619-08CE8972-C69A-4BE6-BEB2-00A8539A70ACQ33815423-ACFE4885-FF70-4637-8177-8C4DEC41FEEBQ34137785-910485B4-A753-458A-8176-C5E92681C0C5Q34206267-0A3C202E-18F8-4156-8E79-0C67FEE8F113Q34395222-CC96F96B-5138-49C5-80D5-DD55202EB831Q34532389-BFFBB5EB-F461-4A16-99FB-7448D09372CCQ34652408-55488D0A-F4B8-4C93-99F5-11D17AFC2F2DQ34802235-EB3B14E7-7326-4A74-96D5-37C07424E816Q35072040-7403A6FF-65BD-48D5-B73F-4F957A065A52Q35092923-D73412FF-1DCF-4A07-9FA7-5CD35C5C84BBQ35883004-DB698995-633B-466D-A6A7-16D26455A4A1Q35883452-66BA6D23-8A68-4474-BAC5-02FB19054946Q36123941-915D6867-9BF6-487A-BA36-22629022C3A0Q36914497-E14C324C-1054-4798-BBE9-11C796EC0C14Q37120215-9E7F8B68-4529-4B63-B5CD-36B94A1B97FCQ37120229-A2ABF974-86D7-451E-994B-6E66E7017AFDQ37294760-D1E73381-E904-4CAA-AF4B-DB64844093B8Q37515155-5BC8F382-3B00-4BDC-8379-649C82EEDC26Q37714642-640EDB98-0A6D-4C50-93AD-374603AF3C5BQ37729376-E63D7123-34C8-4F82-90A8-A8798A9D0350Q37731978-2F1329E4-6314-48BE-ABAE-3E1B00264C80Q37990046-7901B6D9-01C9-4DED-A5CD-6210732482D9Q38016451-059F0C9A-856D-4818-9526-2E1F67C92AA6Q38051222-801F9CE3-A3B8-4B45-910A-11AEFFFB0A6DQ38051730-2F3D0017-BF70-44A8-B129-9E5863C7010BQ38052064-19208085-8520-4851-842B-3398C4191E2AQ38280462-4FC0EDAF-58A6-47A0-B424-673C8EB0C84BQ38787725-B156B00D-D2E4-424F-9FC9-D56D8D0B115AQ39104547-0C730217-3650-4B6A-95A9-6CA1691D6F23Q39255203-FA9E01FE-0504-4CFB-942D-3508A1C5A8C2Q39672046-A37BD900-583D-47B0-A452-E5665379E527Q40039875-F1989EDB-A86B-4F66-BBDB-8671EF6C79DAQ40101148-3722F9B6-4345-4DEB-8B62-A2543344351EQ40213985-D3582CF9-B4B8-4CFA-B4D2-6046642A82A8Q40274003-BD9A4B14-D37B-4CE2-9A92-3E3FD0F573D5Q40604193-F878F5BD-3C21-4AE4-B9B6-48CDEC56303EQ40655396-206D52CB-13B4-4FFC-AEE2-1740426CE006Q40953833-3C7E24A4-824C-4FDC-A9AA-52A340C44C91
P2860
Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Isopentenyl pyrophosphate-acti ...... human squamous cell carcinoma.
@en
Isopentenyl pyrophosphate-acti ...... human squamous cell carcinoma.
@nl
type
label
Isopentenyl pyrophosphate-acti ...... human squamous cell carcinoma.
@en
Isopentenyl pyrophosphate-acti ...... human squamous cell carcinoma.
@nl
prefLabel
Isopentenyl pyrophosphate-acti ...... human squamous cell carcinoma.
@en
Isopentenyl pyrophosphate-acti ...... human squamous cell carcinoma.
@nl
P2093
P2860
P1476
Isopentenyl pyrophosphate-acti ...... human squamous cell carcinoma.
@en
P2093
Alan A Z Alexander
Amudhan Maniar
Andrei I Chapoval
Andrew M Hebbeler
Brian R Gastman
C David Pauza
Dan H Schulze
Jean-Saville Cummings
Scott E Strome
P2860
P304
P356
10.1158/1078-0432.CCR-07-4912
P407
P577
2008-07-01T00:00:00Z